First Time Loading...

Mirum Pharmaceuticals Inc
NASDAQ:MIRM

Watchlist Manager
Mirum Pharmaceuticals Inc Logo
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Watchlist
Price: 25.84 USD 0.94% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

MIRM Price Targets Summary
Mirum Pharmaceuticals Inc

Wall Street analysts forecast MIRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MIRM is 49.89 USD with a low forecast of 33.33 USD and a high forecast of 75.6 USD.

Lowest
Price Target
33.33 USD
29% Upside
Average
Price Target
49.89 USD
93% Upside
Highest
Price Target
75.6 USD
193% Upside

MIRM Last Price Targets
Mirum Pharmaceuticals Inc

The latest public price target was made on Apr 16, 2024 by Dae Gon Ha from Stifel Nicolaus , who expects MIRM stock to rise by 86% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Dae Gon Ha
Stifel Nicolaus
48 USD
Upside 86%
2 weeks ago
Apr 16, 2024
Mirum Pharmaceuticals initiated with a Buy at Stifel
TheFly
Ed Arce
H.C. Wainwright
58 USD
Upside 124%
1 month ago
Mar 14, 2024
Mirum Pharamceuticals (MIRM) PT Raised to $58 at H.C. Wainwright
StreetInsider
Dae Gon Ha
Stifel Nicolaus
Price Target 48 USD
Upside/Downside 86%
View Source
Ed Arce
H.C. Wainwright
Price Target 58 USD
Upside/Downside 124%
View Source
Mirum Pharmaceuticals Inc Competitors:
Price Targets
300639
Guangdong Hybribio Biotech Co Ltd
540% Upside
SRZN
Surrozen Inc
237% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
7% Upside
BIOPOR
Bioporto A/S
286% Upside
AVCT
Avacta Group PLC
107% Upside
002880
Shenzhen Weiguang Biological Products Co Ltd
43% Upside
PHM
Pharma Mar SA
70% Upside
GRTS
Gritstone bio Inc
447% Upside

Revenue
Forecast

Revenue Estimate
Mirum Pharmaceuticals Inc

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 3 years is 43%.

N/A
Past Growth
43%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat

Net Income
Forecast

Net Income Estimate
Mirum Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MIRM's stock price target?
Price Target
49.89 USD

According to Wall Street analysts, the average 1-year price target for MIRM is 49.89 USD with a low forecast of 33.33 USD and a high forecast of 75.6 USD.

What is Mirum Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
43%

The compound annual growth rate of Mirum Pharmaceuticals Inc's revenue for the next 3 years is 43%.